Norges Bank’s Pulse Biosciences PLSE Stock Holding History

Norges Bank’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,000	Closed	-$302K	–	1149
2025 Q2	$302K	Hold	20,000	–	–	﹤0.01%	1668
2025 Q1	$322K	Hold	20,000	–	–	﹤0.01%	1713
2024 Q4	$348K	Buy	+20,000	New	+$353K	﹤0.01%	1810

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Norges Bank's PLSE Position: Q3 2025 in Review

Norges Bank sold out of Pulse Biosciences (PLSE) in Q3 2025, closing a stake of 20,000 shares — an estimated $302K sold.

Norges Bank first reported a position in PLSE in Q4 2024 and held it in 3 quarters. The position peaked at $348K in Q4 2024. 84 funds tracked by Wall St. Rank hold PLSE as of Q3 2025.

Norges Bank reported no remaining Pulse Biosciences position as of Q3 2025 after selling out during the quarter.
Norges Bank sold 20,000 Pulse Biosciences shares in Q3 2025, an estimated $302K.
Norges Bank first reported a position in Pulse Biosciences in Q4 2024 and held it in 3 quarters.
Norges Bank's Pulse Biosciences position peaked at $348K in Q4 2024.
84 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2025.

Based on Norges Bank's 13F filing for Q3 2025.